Nano-X Imaging Raises $8 Million in Registered Direct Offering to Fuel Preventive Healthcare Platform

Nano-X Imaging Ltd. (NASDAQ: NNOX) announced on Monday that it has entered into a securities purchase agreement with a single long-term institutional investor for a registered direct offering expected to generate approximately $8 million in gross proceeds. The financing includes the sale of 8 million ordinary shares, or prefunded warrants in lieu thereof, together with warrants to purchase up to an additional 8 million ordinary shares at a combined purchase price of $1.00 per share and accompanying warrant. The warrants will have an exercise price of $1.15 per share, become exercisable six months after issuance, and expire five years after closing.

The offering is expected to close on or about Aug. 7, 2026, subject to customary closing conditions. Nano-X said it intends to use the net proceeds for working capital and general corporate purposes. A.G.P./Alliance Global Partners is serving as the sole placement agent for the transaction.

This capital raise comes at a pivotal time for Nano-X, which is focused on driving the world’s transition to preventive healthcare by delivering an integrated, end-to-end medical imaging and healthcare services platform. The company combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.

The significance of this offering lies in its potential to accelerate Nano-X's mission to expand the reach of medical imaging both within and beyond traditional hospital settings. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nano-X aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.

The Nanox ecosystem includes several key components: Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provides access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.

By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nano-X seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The new funding will likely support ongoing development and commercialization efforts across these platforms.

This announcement is important because it signals continued investor confidence in Nano-X's vision and provides the company with additional capital to execute its strategy. As the healthcare industry increasingly shifts toward preventive and value-based care, Nano-X's approach of making advanced imaging more accessible and affordable could have significant implications for patient outcomes and healthcare costs. The company's ability to secure funding from a long-term institutional investor suggests a belief in its long-term potential despite the challenges of bringing new medical technologies to market.

For more information, visit Nanox Vision.